These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31436987)

  • 1. An Integrated Markov State Model and Path Metadynamics Approach To Characterize Drug Binding Processes.
    Bernetti M; Masetti M; Recanatini M; Amaro RE; Cavalli A
    J Chem Theory Comput; 2019 Oct; 15(10):5689-5702. PubMed ID: 31436987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor.
    Zocher M; Fung JJ; Kobilka BK; Müller DJ
    Structure; 2012 Aug; 20(8):1391-402. PubMed ID: 22748765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bitopic Ligands Support the Presence of a Metastable Binding Site at the β
    Gaiser BI; Danielsen M; Xu X; Røpke Jørgensen K; Fronik P; Märcher-Rørsted E; Wróbel TM; Liu X; Mosolff Mathiesen J; Sejer Pedersen D
    J Med Chem; 2024 Jul; 67(13):11053-11068. PubMed ID: 38952152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lipid composition on the structural stability of g-protein coupled receptor.
    Mahmood I; Liu X; Neya S; Hoshino T
    Chem Pharm Bull (Tokyo); 2013; 61(4):426-37. PubMed ID: 23546002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Effectively Can Adaptive Sampling Methods Capture Spontaneous Ligand Binding?
    Betz RM; Dror RO
    J Chem Theory Comput; 2019 Mar; 15(3):2053-2063. PubMed ID: 30645108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Girsanov reweighting for metadynamics simulations.
    Donati L; Keller BG
    J Chem Phys; 2018 Aug; 149(7):072335. PubMed ID: 30134671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Principles of Ligand Specificity on beta-2-adrenergic receptor.
    Chan HC; Filipek S; Yuan S
    Sci Rep; 2016 Oct; 6():34736. PubMed ID: 27703221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.
    Vilar S; Karpiak J; Berk B; Costanzi S
    J Mol Graph Model; 2011 Apr; 29(6):809-17. PubMed ID: 21334234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand induced change of β2 adrenergic receptor from active to inactive conformation and its implication for the closed/open state of the water channel: insight from molecular dynamics simulation, free energy calculation and Markov state model analysis.
    Bai Q; Pérez-Sánchez H; Zhang Y; Shao Y; Shi D; Liu H; Yao X
    Phys Chem Chem Phys; 2014 Aug; 16(30):15874-85. PubMed ID: 24962153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway and mechanism of drug binding to G-protein-coupled receptors.
    Dror RO; Pan AC; Arlow DH; Borhani DW; Maragakis P; Shan Y; Xu H; Shaw DE
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13118-23. PubMed ID: 21778406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metadynamics Enhanced Markov Modeling of Protein Dynamics.
    Biswas M; Lickert B; Stock G
    J Phys Chem B; 2018 May; 122(21):5508-5514. PubMed ID: 29338243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-Binding Calculations with Metadynamics.
    Provasi D
    Methods Mol Biol; 2019; 2022():233-253. PubMed ID: 31396906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Metadynamics-Based Protocol for the Determination of GPCR-Ligand Binding Modes.
    Söldner CA; Horn AHC; Sticht H
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmon-waveguide resonance studies of ligand binding to the human beta 2-adrenergic receptor.
    Devanathan S; Yao Z; Salamon Z; Kobilka B; Tollin G
    Biochemistry; 2004 Mar; 43(11):3280-8. PubMed ID: 15023079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient strategy to estimate thermodynamics and kinetics of G protein-coupled receptor activation using metadynamics and maximum caliber.
    Meral D; Provasi D; Filizola M
    J Chem Phys; 2018 Dec; 149(22):224101. PubMed ID: 30553249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective binding of agonists to the β
    Plazinska A; Plazinski W
    Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of high affinity ligands for β2-adrenergic receptor through pharmacophore-based high-throughput virtual screening and docking.
    Yakar R; Akten ED
    J Mol Graph Model; 2014 Sep; 53():148-160. PubMed ID: 25137647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Application of Alchemical Free Energy Simulations to Discriminate GPCR Ligand Efficacy.
    Lee HS; Seok C; Im W
    J Chem Theory Comput; 2015 Mar; 11(3):1255-66. PubMed ID: 26579772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping functional group free energy patterns at protein occluded sites: nuclear receptors and G-protein coupled receptors.
    Lakkaraju SK; Yu W; Raman EP; Hershfeld AV; Fang L; Deshpande DA; MacKerell AD
    J Chem Inf Model; 2015 Mar; 55(3):700-8. PubMed ID: 25692383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast, metadynamics-based method for prediction of the stereochemistry-dependent relative free energies of ligand-receptor interactions.
    Plazinska A; Plazinski W; Jozwiak K
    J Comput Chem; 2014 Apr; 35(11):876-82. PubMed ID: 24615679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.